Department of Nephrology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen 518037, China.
Iran J Kidney Dis. 2020 Dec;14(6):454-462.
To investigate the relationship between serum IgG (sIgG) concentration and the prognosis of IgA nephropathy (IgAN).
A total of 309 patients with biopsy-proven IgAN in the Second Referral Hospital of Shenzhen were enrolled between 2010/01 and 2017/06. Patients were divided into 3 groups on the basis of sIgG tertiles: < 8.99 g/L (Group G1), 8.99 to 11.17 g/L (Group G2), and > 11.17 g/L (Group G3).
As the level of sIgG increased, there was a decrease in DBP, serum creatinine, 24h urine proteinuria and an increase in serum albumin (all P < .05). In terms of pathological manifestations, with increasing sIgG levels, there was a tendency of decline in the Lee's grading system or high-grade tubular atrophy/interstitial fibrosis or in the proportion of glomerular sclerosis and the ratio of crescent (all P < .05). Kaplan-Meier analysis indicated that the cumulative renal survivals rates were significantly higher in patients with elevated sIgG (P < .05). Cox regression analysis showed that after adjusting for gender, age, BMI, and clinical indicators (BP, 24h urine proteinuria, eGFR, M, E, S, T, and the ratio of crescent), decreased sIgG level at the time of renal biopsy is an independent risk factor for unfavorable outcomes in IgAN. Furthmore, every 1 g/L decrease in sIgG level was associated with a 1.74-fold (95% CI: 1.30 to 5.38) increased risk of the incidence of composite renal outcomes.
Decreased serum IgG level at baseline might be a kind of predictive marker for the poor prognosis of IgAN.
为了研究血清 IgG(sIgG)浓度与 IgA 肾病(IgAN)预后的关系。
2010 年 1 月至 2017 年 6 月,共纳入在深圳第二附属医院经肾活检证实为 IgAN 的 309 例患者。根据 sIgG 三分位数将患者分为 3 组:<8.99g/L(G1 组)、8.99~11.17g/L(G2 组)和>11.17g/L(G3 组)。
随着 sIgG 水平的升高,DBP、血清肌酐、24 小时尿蛋白和血清白蛋白降低(均 P<0.05)。在病理表现方面,随着 sIgG 水平的升高,Lee 分级系统呈下降趋势,或高等级肾小管萎缩/间质纤维化,或肾小球硬化和新月体比例呈上升趋势(均 P<0.05)。Kaplan-Meier 分析表明,sIgG 升高患者的累积肾脏存活率显著较高(P<0.05)。Cox 回归分析显示,在调整性别、年龄、BMI 和临床指标(BP、24 小时尿蛋白、eGFR、M、E、S、T 和新月体比例)后,肾活检时 sIgG 水平降低是 IgAN 不良结局的独立危险因素。此外,sIgG 水平每降低 1g/L,复合肾脏结局的发生风险增加 1.74 倍(95%CI:1.30~5.38)。
基线时血清 IgG 水平降低可能是 IgAN 预后不良的一种预测标志物。